Brief: Sumitomo Pharma, Pfizer Canada Announce Availability Of MYFEMBREE In Canada
31/01/2024 14:25
Jan 31 (Reuters) - Sumitomo Pharma Co Ltd 4506.T :
* SUMITOMO PHARMA AND PFIZER CANADA ANNOUNCE AVAILABILITY OF
MYFEMBREE® IN CANADA
Source text for Eikon: ID:nCNWlsFyya
Further company coverage: 4506.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sumitomo Pharma
See all newsSumitomo Pharma America Announces First Patient Receives Treatment In Phase 1/2A Study For Investigational Therapy Dsp-3077 For Retinitis Pigmentosa
Regarding A Report Concerning Sumitomo Pharma ( Company's Views On Gcr August 7 Report)
Brief: Sumitomo Pharma - Gotham City Research's August 3 Report Contains Numerous Statements That Are Clearly Inconsistent With Facts
Brief: Gotham City Research Holds Short Positions In Sumitomo Chemical And Sumitomo Pharmaceutical
Table: Sumitomo Pharma -Q1 group results (IFRS)